{
  "authors": [
    {
      "author": "Alessandra Iacono"
    },
    {
      "author": "Monica Sprocati"
    },
    {
      "author": "Anna Lisa Giuliani"
    },
    {
      "author": "Francesco Di Virgilio"
    },
    {
      "author": "Caterina Borgna-Pignatti"
    },
    {
      "author": "Giuseppe Maggiore"
    }
  ],
  "doi": "10.1186/s13052-019-0664-4",
  "publication_date": "2019-06-27",
  "id": "EN112166",
  "url": "https://pubmed.ncbi.nlm.nih.gov/31234906",
  "source": "Italian journal of pediatrics",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "Here we report the case of a 5 years-old girl with SoJIA complicated by severe thrombocytosis. Treatment with the Interleukin-1β (IL-1β) receptor antagonist Anakinra caused a fast reduction of blood platelets and of the associated systemic inflammatory response. Measurement of IL-1β, IL-6 and Tpo plasma levels at different time points confirmed the etiopathogenetic role of IL-1β in causing the thrombocytosis, while Tpo did not appear to be involved and this explains the excellent response to treatment with Anakinra."
}